|
 |
EDITOR'S PAGE
Breaking Ground in the Treatment of Retinal Diseases
By Conni Koury, Editor-in-Chief
MEDICAL RETINA
EAGLE to Study Central Retinal Artery Occlusion
By Conni Bergmann Koury, Editor-in-Chief
Retinal Microvascular Abnormalities, Cardiovascular Mortality Linked
Reviewed By Alun D. Hughes, MBBS, PhD, BSc
DIABETES
Treatment of DR With Somatostatin Analogues:
Where Do We Go From Here?
By Stela S. Palii, MD, and Maria B. Grant, MD
Glycosylation Enzyme Inhibition May Provide
Novel Rationale for Diabetic Retinopathy Treatment
Reviewed By Rakesh Chibber, PhD
Pegaptanib Can Reduce Proliferative Diabetic Retinopathy Progression
By Conni Bergmann Koury, Editor-in-Chief
RETINAL IMAGING
Newer Endoilluminators Ease 25-Gauge Surgery
By Allen C. Ho, MD
Corneal Dryness Affects OCT Scan Quality
By Conni Bergmann Koury, Editor-in-Chief
COVER FOCUS
FDA Approved Ranibizumab for Neovascular AMD
By Conni Bergmann Koury, Editor-in-Chief
CFH Polymorphism May Cause More Than Half of All AMD Cases
Reviewed By Paulus T.V.M. de Jong, MD. PhD
AMD Linked to Stroke Risk
Reviewed By Tien Yin Wong, MD, MPH, PhD
Minimally Depressed AMD Patients Suffer Additional Declines in Vision
Reviewed By Barry W. Rovner, MD
PDT Beneficial in Eyes With CNV, Submacular Hemorrhage and AMD
Reviewed By Paul M. Beer, MD
Niacin Produces Vasodilation of the Retinal Arterioles
Reviewed By Juan E. Grunwald, MD
Clinical Trial Update: AMD
Continuing Medical Education
Innovations
5 Questions: Alan Bird, MD |
|
|
